Cross-Over Comparison and New Chemotherapy Regimens in Metastatic Pancreatic Cancer

Memo - Magazine of European Medical Oncology - Austria
doi 10.1007/s12254-017-0352-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Meta‑analysis of Current Chemotherapy Regimens in Advanced Pancreatic Cancer to Prolong Survival and Reduce Treatment‑associated Toxicities

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

Chemotherapy for Pancreatic Cancer

Baillière's Clinical Gastroenterology
1990English

Trastuzumab-Containing Regimens for Metastatic Breast Cancer

Cochrane Database of Systematic Reviews
2014English

Metronomic Chemotherapy in Metastatic Breast Cancer

Novel Research in Sciences
2019English

Combination Chemotherapy in Metastatic Breast Cancer

BMJ
1977English

Combination Chemotherapy in Metastatic Breast Cancer

InPharma
1977English

New Option for the Initial Management of Metastatic Pancreatic Cancer?

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2014English

RUNX3 Expression in Primary and Metastatic Pancreatic Cancer

Journal of Clinical Pathology
MedicineForensic MedicinePathology
2004English

FOLFOX as Second-Line Chemotherapy in Patients With Pretreated Metastatic Pancreatic Cancer From the FIRGEM Study

BMC Cancer
Cancer ResearchOncologyGenetics
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy